Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | ACE | P12821 | 3/20 | 0.55 |
| ▸ | FPR2 | P25090 | 1/20 | 0.54 |
| ▸ | ITGB2 | P05107 | 4/20 | 0.53 |
| ▸ | ICAM1 | P05362 | 4/20 | 0.53 |
| ▸ | ITGAL | P20701 | 4/20 | 0.53 |
| ▸ | NMBR | P28336 | 2/20 | 0.52 |
| ▸ | MDM4 | O15151 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | ECE1 | P42892 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL850319 | 1.00 | ALOX15 (0.56) | ALOX15ACEFPR2ITGB2ICAM1 | |
| SCHEMBL29350138 | 1.00 | ALOX15 (0.56) | ALOX15ACEFPR2ITGB2ICAM1 | |
| SCHEMBL29417397 | 1.00 | ALOX15 (0.56) | ALOX15ACEFPR2ITGB2ICAM1 | |
| SCHEMBL29350130 | 1.00 | ALOX15 (0.56) | ALOX15ACEFPR2ITGB2ICAM1 | |
| SCHEMBL119594 | 1.00 | ALOX15 (0.56) | ALOX15ACEFPR2ITGB2ICAM1 | |
| Water SCHEMBL6022940 | 0.99 | ALOX15 (0.55) | ALOX15ACEFPR2ITGB2ICAM1 | |
| Fluoride SCHEMBL7154596 | 0.99 | ALOX15 (0.55) | ALOX15ACEFPR2ITGB2ICAM1 | |
| SCHEMBL29903356 | 0.93 | NMBR (0.55) | ACENMBRECE1 | |
| SCHEMBL30310986 | 0.93 | ACE (0.53) | ACEECE1 | |
| SCHEMBL29903302 | 0.93 | NMBR (0.55) | ACENMBRECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116075499-A | Novel dephosphorylated galectin derivatives with prodrug properties | 指南针探路者有限公司 | 2023-05-05 | — | — | CN | claimed |
| CN-110180022-B | Shear force response supramolecular bionic articular cartilage material with dynamic lubrication self-repair capacity and preparation method thereof | 吉林大学 | 2021-11-05 | — | — | CN | claimed |
| CN-112110834-A | Modified hydrophobic auxiliary material and preparation method and application thereof | 浙江智达药业有限公司 | 2020-12-22 | — | — | CN | claimed |
| CN-107670104-B | Preparation method of self-lubricating bionic articular cartilage with shear force response | 吉林大学 | 2020-07-03 | — | — | CN | claimed |
| EP-3429354-A1 | B-VITAMIN AND AMINO ACID CONJUGATES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, DERIVATIVES THEREOF, AND METHODS OF PREPARATION THEREOF | Chromadex Inc. (US) | 2019-01-23 | — | — | EP | claimed |
| US-10000520-B2 | B-vitamin and amino acid conjugates ofnicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof | ChromaDex Inc. (US) | 2018-06-19 | — | — | US | claimed |
| US-20170267709-A1 | B-VITAMIN AND AMINO ACID CONJUGATES OFNICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, DERIVATIVES THEREOF, AND METHODS OF PREPARATION THEREOF | ChromaDex Inc. (US) | 2017-09-21 | — | — | US | claimed |
| WO-2017161165-A1 | B-VITAMIN AND AMINO ACID CONJUGATES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, DERIVATIVES THEREOF, AND METHODS OF PREPARATION THEREOF | ChromaDex Inc. (US) | 2017-09-21 | — | — | WO | claimed |
| CN-105585613-A | Eptifibatide synthesis method | HE RUNZE | 2016-05-18 | — | — | CN | claimed |
| CN-102775471-B | Method for synthesizing cholecystokinin octapeptide by combining solid phase method and liquid phase method | GL BIOCHEM SHANGHAI CO LTD | 2013-10-30 | — | — | CN | claimed |
| CN-102775471-A | Method for synthesizing cholecystokinin octapeptide by combining solid phase method and liquid phase method | GL BIOCHEM SHANGHAI CO LTD | 2012-11-14 | — | — | CN | claimed |
| CN-100590068-C | Method for preparing primary amine carbon nano tube | UNIV TONGJI | 2010-02-17 | — | — | CN | claimed |
| US-12415835-B2 | Peptide-compound cyclization method | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-09-16 | — | — | US | disclosed |
| CN-120081948-A | Co-assembly of self-assembled short peptide and recombinant III type collagen, and preparation method and application thereof | 常州市智态生创科技有限公司 | 2025-06-03 | — | — | CN | disclosed |
| WO-2025043696-A1 | ANTIVIRAL POLYPEPTIDE ANALOGUE | 上海多米瑞生物技术有限公司 | 2025-03-06 | — | — | WO | disclosed |
| US-20240166689-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-05-23 | — | — | US | disclosed |
| WO-1998025949-A1 | SUBSTITUTED 5-AMINO-1,3,4-THIADIAZOLE-2-THIONES | PROSCRIPT, INC. (US) | 1998-06-18 | — | — | WO | disclosed |
| EP-0845002-A2 | AMINO ACID AMIDES OF 5-AMINO-1,3,4-THIADIAZONES AND THEIR USE AS INHIBITORS FOR MATRIX METALLOPROTEINASES | PROSCRIPT, INC. (US) | 1998-06-03 | — | — | EP | disclosed |
| US-5677282-A | ENZYME INHIBITOR; OSTEOARTHRITIS AND RHEUMATIC DISORDERS | PROSCRIPT, INC. (US) | 1997-10-14 | — | — | US | disclosed |
| WO-1996040745-A2 | AMINO ACID AMIDES OF 5-AMINO-1,3,4-THIADIAZONES AND THEIR USE AS INHIBITORS FOR MATRIX METALLOPROTEINASES | PROSCRIPT, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10000520-B2 | B-vitamin and amino acid conjugates ofnicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof | NAMPT, NAPRT, NNMT | ALOX15 2013/4885ACE 4681/4885FPR2 307/4885 |
| US-20240166689-A1 | PEPTIDE-COMPOUND CYCLIZATION METHOD | VIP, NGLY1, GLP1R | ALOX15 3621/4885ACE 621/4885FPR2 190/4885 |
| US-20170267709-A1 | B-VITAMIN AND AMINO ACID CONJUGATES OFNICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, DERIVATIVES THEREOF, AND METHODS OF PREPARATION THEREOF | NAMPT, NAPRT, NNMT | ALOX15 2013/4885ACE 4681/4885FPR2 307/4885 |
| US-12415835-B2 | Peptide-compound cyclization method | VIP, NGLY1, GLP1R | ALOX15 3621/4885ACE 621/4885FPR2 190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.